By Daniel Wilson ( March 9, 2016, 8:59 PM EST) -- Intelligent Bio-Systems Inc. on Wednesday urged the Federal Circuit to overturn a Patent Trial and Appeal Board ruling affirming the validity of rival Illumina Cambridge Ltd.'s DNA sequencing patent, saying the board had set too high a standard to show that a combination of related earlier work rendered the patent obvious....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.